• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Contract Services

Stevanato Group, Owen Mumford to collaborate on Aidaptus auto-injector

May 4, 2022 By Sean Whooley

Owen Mumford aidaptus cms_2 Stevanato Group

Stevanato Group (NYSE:STVN) announced today that it signed an exclusive agreement with Owen Mumford for its auto-injector technology. Piombino Dese, Italy-based Stevanato Group’s agreement makes it an exclusive manufacturing partner for Owen Mumford’s Aidaptus auto-injector. Under the agreement, Stevanato Group will mold the components for the technology and provide final and sub-assembly equipment, along with […]

Filed Under: Auto-injectors, Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: Owen Mumford, Stevanato Group

TriMas completes purchase of Omega Plastics

December 20, 2021 By Chris Newmarker

TriMas Omega Plastics

TriMas (NASDAQ: TRS) announced today that it has completed its acquisition of medical device components maker Omega Plastics. The financial terms of the deal were not disclosed. Omega (Clinton Township, Michigan) expects to bring in $18 million in revenue in fiscal year 2021. Omega Plastics boasts core injection molding capabilities, an ISO Class 8 clean […]

Filed Under: Business/Financial News, Contract Services, Featured Tagged With: Omega Plastics, TriMas

Fareva, ApiJect ink 10-year licensing agreement on fill-finish production lines

December 9, 2021 By Sean Whooley

Apiject

Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year. Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: ApiJect Systems

Baxter bolsters fill-finish capabilities with $100M investment in Germany

November 18, 2021 By Brian Buntz

Baxter

Baxter International (NYSE:BAX) plans to invest roughly $100 million to expand a sterile fill-finish manufacturing plant in Halle/Westfalen, Germany. BioPharma Solutions (BPS), a subsidiary of Deerfield, Illinois–based Baxter, will manage the new facility. BPS supports pharmaceutical companies through a range of offerings, including scientific support, sterile contract manufacturing and parenteral delivery systems. Get the full […]

Filed Under: Contract Services Tagged With: Baxter, Baxter International, BioPharma Solutions, BPS

BD breaks ground on pre-filled syringe manufacturing plant in Spain

November 16, 2021 By Sean Whooley

BD

BD (NYSE:BDX) announced today that it broke ground on its $200 million pre-filled drug delivery device manufacturing plant in Spain. Franklin Lakes, New Jersey-based BD announced in May that it would build the $201.5 million (€165 million) high-tech manufacturing facility in Zaragoza, Spain, with expectations of creating up to 600 jobs at the facility by 2030. […]

Filed Under: Auto-injectors, Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: BD

World faces a shortage of up to 2 billion COVID-19 vaccine syringes

November 9, 2021 By Sean Whooley

Pfizer COVID-19 vaccine

The World Health Organization (WHO) reportedly warned that a massive shortage of syringes for COVID-19 vaccines could be on the horizon. Reuters reported that WHO  expert Lisa Hedman told a United Nations briefing that the potential shortage of 1 billion to 2 billion syringes could slow down routine immunizations and create issues with needle safety […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: coronavirus, COVID-19, UNICEF, World Health Organization

Phillips-Medisize expands its global manufacturing capacity

October 19, 2021 By Sean Whooley

PhillipsMedisizeupdated

Phillips-Medisize announced today that it expanded its global manufacturing capacity through several collaborations and internal initiatives. Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world. Get the full story […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: Phillips-Medisize

New BD syringe manufacturing lines are up and running in Nebraska

October 7, 2021 By Sean Whooley

BD

BD (NYSE:BDX) announced today that it increased its manufacturing capacity and domestic supply for syringes and needles. Franklin Lakes, N.J.-based BD’s new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represent BD’s partnership with Department of Health and Human Services’ (HHS) Assistant Secretary for Preparedness and Response (ASPR). In July 2020, […]

Filed Under: Auto-injectors, Business/Financial News, Contract Services, Drug-Device Combinations, Featured Tagged With: BARDA, BD, Becton Dickinson, coronavirus, COVID-19, HHS

Xeris, Tetra Pharma enter $71M licensing agreement for glucagon injection

July 19, 2021 By Sean Whooley

Xeris Tetris Pharma

Xeris Pharmaceuticals (NSDQ:XERS) announced today that it entered into an exclusive agreement with Tetris Pharma to commercialize Ogluo. Chicago-based Xeris designed Ogluo (Gvoke PFS and Gvoke HypoPen in the U.S.) to be a ready-to-use, pre-mixed, pre-measured glucagon injection for treating severe hypoglycemia in adults, adolescents and children two years of age and older with diabetes […]

Filed Under: Business/Financial News, Contract Services, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Tetris Pharma, Xeris Pharmaceuticals, xerispharmaceuticals

GM Instruments, Sensonics partner on nasal and oral measurement devices

June 2, 2021 By Sean Whooley

Sensonics GM Instruments

GM Instruments announced today that it partnered with Sensonics to develop devices for the quantitative assessment of nasal and oral function. The companies tout the first-of-its-kind partnership as a bringing together of sensory and engineering expertise for evaluating and treating nasal and oral diseases. Additionally, the companies expect the partnership to establish the influences of […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Otolaryngology Ear, Nose & Throat, Pharmaceuticals Tagged With: GM Instruments, Sensonics

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS